England's NHS to Trial Multi-Cancer Blood Tests in More Than 20,000 Patients
STRIDE-RCT will assess whether blood-based tests can help GPs decide which symptomatic patients need further investigation. It is not a nationwide screening offer, and a positive result will not be a cancer diagnosis.